News
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
Top highlights include: which insurance companies cover the new Alzheimer's drug, advice on how to talk to someone who is hesitant to get the COVID-19 vaccine, employers requiring you to be vaccinated, FDA approval Alzheimer drug, MN COVID-19 numbers heading in the right direction, having "brain frog" and blaming the pandemic.
Top highlights include: what pain relievers you should take after surgery, COVID fear vs hope, expansion on insurance coverage for Medicare-Medicaid, DASH diets may cause more harm than good with high blood pressure, Mayo Clinic offering new "National Cancer Survivor day" video bilingual series, and the new launch of a Mayo Clinic southern mobile unit.
Dr. Hipp is a board-certified pathologist with fellowship training in pathology informatics, as well as artificial intelligence, machine, and deep-learning experience.
Due to the Memorial Day holiday (recognized on Monday, May 31), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead and note:
In April 2021, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
On Tuesday, May 11, 2021, several changes will be made to the information displayed on the Mayo Clinic Laboratories online test catalog. These changes will improve accuracy and clarity of important information regarding test performanc
The Office of Decedent Affairs plays a key role in Mayo Clinic’s mission as its staff guide families through the logistics and complexities of a loved one’s death with skill and empathy.
The pandemic has brought forth extraordinary challenges but also shined a light on the importance of laboratory professionals in health care.
Dr. Guenzel, a fellow in Laboratory Genetics and Genomics at Mayo Clinic, is the recipient of this award for his publication “The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease.”
Dr. Mills’ experience working with live cell bio-assays propelled him to centerstage in Mayo Clinic’s pursuit of a test to neutralize COVID-19 antibodies and aid in the development of therapies derived from COVID-19 patients' donated plasma.
On April 6, 2020, months of nonstop work for Dr. Theel and her team culminated when Mayo Clinic’s first COVID-19 antibody test — the first commercial antibody test in the nation — was implemented.
Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.